VDR inhibitors represent a distinctive and compelling subclass within the realm of chemical compounds, acclaimed for their remarkable ability to selectively modulate the intricate activity of the vitamin D receptor (VDR). Functioning as a pivotal nuclear receptor, the VDR orchestrates a highly nuanced and orchestrated array of molecular responses, primarily facilitated by the potent metabolite 1,25-dihydroxyvitamin D3, commonly known as calcitriol. It is within this context that VDR inhibitors assume a prominent role, exerting their influence through deliberate and calculated interactions with the VDR protein. At the core of their mechanism lies a sophisticated interplay; VDR inhibitors elegantly navigate the structural contours of the VDR protein, engaging with a specific and vital domain known as the ligand-binding domain. This strategic engagement within the VDR protein architecture forms the fulcrum upon which the cascade of downstream intracellular signaling pathways and gene transcription events pivot. Notably, this dynamic interplay is central to the activation process triggered by the natural ligand calcitriol.
The specialized structural framework that characterizes VDR inhibitors aligns harmoniously with the VDR's ligand-binding domain, conferring upon these compounds an inherent ability to intricately modulate the receptor's activity. By virtue of this interaction, VDR inhibitors orchestrate a highly nuanced and context-dependent gene expression profile. This constellation of genes, meticulously influenced by the presence of VDR inhibitors, encompasses a diverse panorama of physiological processes, each contributing to the complex tapestry of cellular function. As the scientific exploration of VDR inhibitors continues to unfold, it underscores a dynamic and evolving quest to unravel the intricate regulatory networks interwoven within the VDR's domain. This continuous refinement of knowledge deepens our understanding of the multifaceted interplay between VDR inhibitors and the delicate choreography of molecular responses guided by the VDR and its ensemble of ligands.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
An antifungal agent that has been shown to inhibit VDR activity by competing with Vitamin D for binding to the receptor. | ||||||
Calcipotriol | 112965-21-6 | sc-203537 sc-203537A | 10 mg 50 mg | $203.00 $832.00 | 4 | |
Also known as calcipotriene, this synthetic derivative of Vitamin D3 is studied in the research of psoriasis. It can bind to VDR and regulate cell proliferation and differentiation. | ||||||
Tenofovir | 147127-20-6 | sc-204335 sc-204335A | 10 mg 50 mg | $157.00 $646.00 | 11 | |
An antiretroviral agent used in the studies of HIV and hepatitis B. It has been shown to modulate VDR activity. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Primarily used to lower cholesterol levels, gemfibrozil has been investigated for its potential to inhibit VDR and impact Vitamin D-mediated processes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A natural compound found in turmeric, curcumin has anti-inflammatory and antioxidant properties. It has been suggested to interfere with VDR activity, potentially affecting immune responses. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Found in red wine and grapes, resveratrol has been studied for its potential to inhibit VDR activity, impacting pathways related to aging and disease. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil has been investigated for its ability to modulate VDR-mediated processes. | ||||||
Chenodeoxycholic acid, free acid | 474-25-9 | sc-278835 sc-278835A | 1 g 5 g | $28.00 $117.00 | ||
Another bile acid derivative that has been explored as a VDR inhibitor, potentially affecting Vitamin D-related functions. | ||||||
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $43.00 | 8 | |
A broad-spectrum antibiotic that has been shown to interfere with VDR signaling, suggesting a potential impact on immune responses. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin has been studied for its effects on VDR activity. | ||||||